Netupitant and Palonosetron Hydrochloride
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Netupitant and Palonosetron Hydrochloride, covering 2021-06-03 to 2023-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer [Phase 2, Phase 3]